Pancreatic Cancer Research

ResearcherNational Sun Yat-sen UniversityActive in the last 2 years

Min‐Wu Chao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9122-3415; OpenAlex author ID A5024350727. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 3

  1. Discovery of a novel RSK2 inhibitor for the treatment of metastatic pancreatic cancer. Last author DOI 10.1080/14756366.2025.2538673↗
  2. In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer. First author DOI 10.1080/14756366.2023.2166039↗
  3. Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status. Co-author DOI 10.1186/s13148-019-0681-6↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shiow‐Lin Pan · 3 shared papers, 2019–2025 · strength 0.57
  2. Kai‐Cheng Hsu · 2 shared papers, 2023–2025 · strength 0.47
  3. Chi-Hsiu Chung · 1 shared paper, 2025 · strength 0.30
  4. Chao-Di Chang · 2 shared papers, 2019–2023 · strength 0.26
  5. Li-Hsun Chang · 1 shared paper, 2019 · strength 0.10
  6. Che‐Ming Teng · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.